Reduction of NICE cost-effectiveness threshold recommended

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.532, 2007-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The NICE Cost-Effectiveness Threshold: What it is and What that Means

By McCabe Christopher

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 733-744

Adis International

Access to resources Recommend Favorite

A closer look at the NICE cost-effectiveness threshold

Inpharma, Vol. 1, Iss. 1659, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

A closer look at the NICE cost-effectiveness threshold

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 564, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

The Citizens Council say that the NICE cost-effectiveness threshold could be exceeded in certain circumstances

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 580, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Healthcare Rationing by Proxy: Cost-Effectiveness Analysis and the Misuse of the $50 000 Threshold in the US

By Bridges John F.P.

PharmacoEconomics, Vol. 28, Iss. 3, 2010-03 ,pp. : 175-184

Adis International

Access to resources Recommend Favorite